Results 111 to 120 of about 3,110,367 (185)
Optimal management strategies for paediatric morphea – insights from a case series
Juvenile localized scleroderma, or morphea, is a rare chronic inflammatory disease primarily affecting the skin and subcutaneous tissue. Treatment options for paediatric cases are diverse, with a lack of standardised guidelines.
Justyna Ceryn +6 more
core +1 more source
Exploring the relationship between morphea and malignancy: a decade-long single-center study of 204 patients [PDF]
The association between systemic scleroderma and malignancy is well-documented, but there is limited data on the relationship between morphea and malignancy. This study aims to assess the incidence and types of malignancies in morphea patients, comparing
Lyakhovitsky K. +3 more
core +1 more source
Morphea “en coup de sabre”: an unusual oral presentation [PDF]
Morphea, or localized scleroderma, is an inflammatory disease that leads to sclerosis of the skin and underlying tissues due to excessive collagen deposition.
Martínez, René +3 more
core
Linear scleroderma en coup de sabre in an adult female: Ocular, adnexal and tomographic features
Sushmita G Shah +4 more
doaj +1 more source
Linear morphea masquerading as superficial thrombophlebitis [PDF]
Michael Jolly, Seth Bendo, Raghu Kolluri
openaire +1 more source
083 Linear morphea with evidence of hair regrowth [PDF]
K. Svigos +4 more
openaire +1 more source
Deep circumscribed morphea: A case report
Idiopathic sclerotic skin illnesses are included under the term "morphea", sometimes known as localized scleroderma. Deep induration of the skin and subcutaneous tissue that extends to the underlying muscle and bone is a feature of the morphea subtype ...
Putri Hendria Wardhani +6 more
core +1 more source
Under the Surface: A Rare Case of the En Coup De Sabre Subtype of Linear Morphea in the Rio Grande Valley. [PDF]
Lopez M, Hensley J, Villegas M.
europepmc +1 more source
Linear morphea: a persistent bruise on the temple of a 9-year-old boy. [PDF]
DeBiasio C, Nizalik E, Gavigan G.
europepmc +1 more source

